Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,4 Diazepane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116143713A reveals a novel 4-step route for 1,4-diazepane derivatives, offering high purity, reduced toxicity, and scalable manufacturing for ROCK inhibitor intermediates.